PM
PBYI icon

Parametrica Management’s Puma Biotechnology PBYI Stock Holding History

Parametrica Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,298
Closed -$244K – 230
2016
Q1 		$244K Buy
+8,298
New +$375K 0.87% 50

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Parametrica Management's PBYI Position: Q2 2016 in Review

Parametrica Management sold out of Puma Biotechnology (PBYI) in Q2 2016, closing a stake of 8,298 shares — an estimated $244K sold.

Parametrica Management first reported a position in PBYI in Q1 2016 and held it in 1 quarter. The position peaked at $244K in Q1 2016. 110 funds tracked by Wall St. Rank hold PBYI as of Q2 2016.

  • Parametrica Management reported no remaining Puma Biotechnology position as of Q2 2016 after selling out during the quarter.
  • Parametrica Management sold 8,298 Puma Biotechnology shares in Q2 2016, an estimated $244K.
  • Parametrica Management first reported a position in Puma Biotechnology in Q1 2016 and held it in 1 quarter.
  • Parametrica Management's Puma Biotechnology position peaked at $244K in Q1 2016.
  • 110 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2016.

Based on Parametrica Management's 13F filing for Q2 2016, filed 22 Jul 2016.